Publications by authors named "Donna S Neuberg"

100Publications

Analysis, identification and visualization of subgroups in genomics.

Brief Bioinform 2020 Sep 21. Epub 2020 Sep 21.

Institute of Medical Systems Biology, and head of Core Unit Bioinformatics, Ulm University, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bib/bbaa217DOI Listing
September 2020

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.

Nat Med 2020 10 3;26(10):1549-1556. Epub 2020 Aug 3.

Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41591-020-1008-zDOI Listing
October 2020

Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism.

Res Pract Thromb Haemost 2020 Jul 23;4(5):860-865. Epub 2020 Jun 23.

Division of Hemostasis and Thrombosis Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/rth2.12377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354400PMC
July 2020

Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias.

Cancer Cell 2019 04;35(4):664-676.e7

Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02445, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2019.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541931PMC
April 2019

Postoperative bridging anticoagulation and left ventricular assist system thrombosis.

J Thromb Thrombolysis 2019 Jan;47(1):57-66

Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-018-1746-7DOI Listing
January 2019

The Benefits of TRTHing along.

Hemasphere 2018 08 27;2(4):e138. Epub 2018 Jul 27.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746002PMC
August 2018

Reply to Z. Wu et al.

J Clin Oncol 2018 09 30;36(25):2657. Epub 2018 May 30.

Donna S. Neuberg, Dana-Farber Cancer Institute; and Harvard T.H. Chan School of Public Health, Boston, MA; Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.9826
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.9826DOI Listing
September 2018

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.

J Clin Oncol 2018 04 2;36(10):942-950. Epub 2018 Feb 2.

Margaretha G.M. Roemer, Robert A. Redd, Fathima Zumla Cader, Christine J. Pak, Sara Abdelrahman, Jing Ouyang, Philippe Armand, Donna S. Neuberg, and Margaret A. Shipp, Dana-Farber Cancer Institute; Geraldine S. Pinkus, Azra H. Ligon, and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Margaretha G.M. Roemer, VU University Medical Center; Jan Paul De Boer, Antoni van Leeuwenhoek Hospital, Lunenburg Phase I/II Consortium, Amsterdam, the Netherlands; Stephanie Sasse, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas University, Rozzano, Milan; Pier Luigi Zinzani, University of Bologna, Bologna, Italy; John Timmerman, University of California, Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Emory University, Atlanta, GA; John Kuruvilla, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Kerry J. Savage, British Columbia Cancer Agency Center for Lymphoid Cancer, Vancouver, British Columbia, Canada; Marek Trneny, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic; Stephen Ansell, Mayo Clinic, Rochester, MN; and Kazunobu Kato, Benedetto Farsaci, and Anne Sumbul, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.3994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877802PMC
April 2018

Statistics Everywhere.

Authors:
Donna S Neuberg

Hemasphere 2018 Jan-Feb;2(1):e30. Epub 2018 Feb 2.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745945PMC
February 2018

Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage.

Proc Natl Acad Sci U S A 2016 11 14;113(48):E7701-E7709. Epub 2016 Nov 14.

Department of Genetics, Harvard Medical School, Boston, MA 02215;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1611673113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137757PMC
November 2016

Biophysical determinants for cellular uptake of hydrocarbon-stapled peptide helices.

Nat Chem Biol 2016 10 22;12(10):845-52. Epub 2016 Aug 22.

Department of Pediatric Oncology, Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nchembio.2153
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055751PMC
http://dx.doi.org/10.1038/nchembio.2153DOI Listing
October 2016

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.

J Clin Oncol 2016 08 11;34(23):2690-7. Epub 2016 Apr 11.

Margaretha G.M. Roemer, Robert A. Redd, Heather Homer, Courtney F. Connelly, Gordon J. Freeman, Philippe Armand, Bjoern Chapuy, Donna S. Neuberg, and Margaret A. Shipp, Dana-Farber Cancer Institute; Azra H. Ligon, Heather H. Sun, and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Margaretha G.M. Roemer and Daphne de Jong, VU University Medical Center, Amsterdam, the Netherlands; and Ranjana H. Advani, Yasodha Natkunam, Sarah E. Daadi, and Richard T. Hoppe, Stanford University Medical Center, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.4482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019753PMC
August 2016

Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010).

Pediatr Blood Cancer 2016 Jun 23;63(6):1012-8. Epub 2016 Feb 23.

Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25928DOI Listing
June 2016

MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice.

Am J Clin Pathol 2016 Feb 1;145(2):166-79. Epub 2016 Feb 1.

From the Department of Pathology, Brigham and Women's Hospital, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcp/aqv028DOI Listing
February 2016

Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea.

Blood 2015 Jun;125(23):3668-9

Division of Hematology, Brigham and Women's Hospital, Boston, MA Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-03-63
Publisher Site
http://dx.doi.org/10.1182/blood-2015-03-635391DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458806PMC
June 2015

Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic Leukemia.

J Clin Oncol 2015 Jul 18;33(19):2205-11. Epub 2015 May 18.

Peter D. Cole, Veena Vijayanathan, Albert Einstein College of Medicine, Bronx, NY; Yaron Finkelstein, Hospital for Sick Children, University of Toronto, Toronto; Philippe Robaey, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada; Kristen E. Stevenson, Traci M. Blonquist, Donna S. Neuberg, Dana-Farber Cancer Institute (DFCI); Lewis B. Silverman, Stephen E. Sallan, DFCI, Boston Children's Hospital, Harvard Medical School; and Deborah P. Waber, DFCI, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/05/18/JCO.2014.59
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.0273
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.0273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477790PMC
July 2015

Loss of function tp53 mutations do not accelerate the onset of myc-induced T-cell acute lymphoblastic leukaemia in the zebrafish.

Br J Haematol 2014 Jul 2;166(1):84-90. Epub 2014 Apr 2.

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12851DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234197PMC
July 2014

Landscape of genomic alterations in cervical carcinomas.

Nature 2014 Feb 25;506(7488):371-5. Epub 2013 Dec 25.

1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [3] Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA [4].

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature12881DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161954PMC
February 2014

Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis.

Cancer 2013 Jul 26;119(14):2620-9. Epub 2013 Apr 26.

Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28106DOI Listing
July 2013

Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study.

Leuk Lymphoma 2013 Sep 30;54(9):1915-20. Epub 2013 Jan 30.

Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.763397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595907PMC
September 2013

Reprise: gemtuzumab ozogamicin for older patients with acute myeloid leukemia.

Authors:
Donna S Neuberg

J Clin Oncol 2012 Nov 17;30(32):3905-6. Epub 2012 Sep 17.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.6592DOI Listing
November 2012

Zebrafish mast cells possess an FcɛRI-like receptor and participate in innate and adaptive immune responses.

Dev Comp Immunol 2011 Jan 19;35(1):125-34. Epub 2010 Sep 19.

IWK Health Centre, Dalhousie University, PO Box 9700, 5850/5980 University Avenue, Halifax, NS B3K 6R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dci.2010.09.001DOI Listing
January 2011